Mozol K, Kwaśniak E, Haponiuk I, Szafranek A, Maruszewski B. Surgical treatment of congenital heart malformation with left-to-right shunt coexists with pulmonary hypertension. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery. 2011;8(1):66-70.
APA
Mozol, K., Kwaśniak, E., Haponiuk, I., Szafranek, A., & Maruszewski, B. (2011). Surgical treatment of congenital heart malformation with left-to-right shunt coexists with pulmonary hypertension. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery, 8(1), 66-70.
Chicago
Mozol, Krzysztof, Ewelina Kwaśniak, Ireneusz Haponiuk, Adam Szafranek, and Bohdan Maruszewski. 2011. "Surgical treatment of congenital heart malformation with left-to-right shunt coexists with pulmonary hypertension". Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery 8 (1): 66-70.
Harvard
Mozol, K., Kwaśniak, E., Haponiuk, I., Szafranek, A., and Maruszewski, B. (2011). Surgical treatment of congenital heart malformation with left-to-right shunt coexists with pulmonary hypertension. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery, 8(1), pp.66-70.
MLA
Mozol, Krzysztof et al. "Surgical treatment of congenital heart malformation with left-to-right shunt coexists with pulmonary hypertension." Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery, vol. 8, no. 1, 2011, pp. 66-70.
Vancouver
Mozol K, Kwaśniak E, Haponiuk I, Szafranek A, Maruszewski B. Surgical treatment of congenital heart malformation with left-to-right shunt coexists with pulmonary hypertension. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery. 2011;8(1):66-70.
Pulmonary hypertension is a significant risk factor of mortality and morbidity in congenital heart malformations with left-to-right shunt. The increased pulmonary blood flow lead to permanent endothelial cells stimulation, consequently to their dysfunction, increased pulmonary vascular resistance, acute or progressive right ventricle failure. The early surgical correction prevent up mention pathological tract. The optimal time of surgery is still leading therapeutic problem. The specific and non-specific treatment of pulmonary vascular resistance would improve surgical results. Extracorporeal membrane oxygenation (ECMO) or lung or heart – lung transplantation are option for patients with contraindications for surgical treatment and/or resistance for up mention treatment.